As of July 2025 DBV Technologies has a market cap of โน23.71 Billion. This makes DBV Technologies the world's 8077th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน23.71 B | 291.69% |
2024 | โน6.05 B | -62.57% |
2023 | โน16.17 B | -32.03% |
2022 | โน23.79 B | 67.99% |
2021 | โน14.16 B | -33.77% |
2020 | โน21.38 B | -71% |
2019 | โน73.74 B | 188.53% |
2018 | โน25.55 B | -67.96% |
2017 | โน79.76 B | -30.86% |
2016 | โน115.37 B | -1.24% |
2015 | โน116.82 B | 79.88% |
2014 | โน64.94 B |
On Jul 28th, 2025 the market cap of DBV Technologies was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Ionis Pharmaceuticals
IONS | โน567.77 B | 2,294.30% | ๐บ๐ธ USA |
![]() Flexion Therapeutics
FLXN | โน39.76 B | 67.69% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | โน3.669 T | 15,374.16% | ๐บ๐ธ USA |